Mean change in DAS28-ESR by course and by re-treatment status.
| Course 2, n = 317 | Course 3, n = 259 | Course 4, n = 195 | ||||
|---|---|---|---|---|---|---|
| W Course 3, n = 235 | W/O Course 3, n = 40 | W Course 4, n = 176 | W/O Course 4, n = 48 | W Course 5, n = 109 | W/O Course 5 n = 48 | |
| Change in DAS28-ESR at Week 24*, mean (SD) | −2.68 (1.39) | −2.87 (1.07) | −2.88 (1.44) | −3.36 (1.38) | −2.94 (1.58) | −3.10 (1.50) |
↵* Relative to baseline value at the initial rituximab treatment. DAS28-ESR: Disease Activity Score in 28 joints-erythrocyte sedimentation rate; W: with (received subsequent treatment course); W/O: without (did not receive subsequent treatment course).